These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2183815)

  • 41. Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization.
    Townsley S; Mohamed Z; Guo W; McKenna J; Cleveland B; LaBranche C; Beaumont D; Shen X; Yates NL; Pinter A; Tomaras GD; Ferrari G; Montefiori DC; Hu SL
    J Virol; 2016 Oct; 90(19):8644-60. PubMed ID: 27440894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of the outer domain of the gp120 glycoprotein from human immunodeficiency virus type 1.
    Yang X; Tomov V; Kurteva S; Wang L; Ren X; Gorny MK; Zolla-Pazner S; Sodroski J
    J Virol; 2004 Dec; 78(23):12975-86. PubMed ID: 15542649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites.
    Kwong PD; Doyle ML; Casper DJ; Cicala C; Leavitt SA; Majeed S; Steenbeke TD; Venturi M; Chaiken I; Fung M; Katinger H; Parren PW; Robinson J; Van Ryk D; Wang L; Burton DR; Freire E; Wyatt R; Sodroski J; Hendrickson WA; Arthos J
    Nature; 2002 Dec; 420(6916):678-82. PubMed ID: 12478295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity.
    Barbas CF; Hu D; Dunlop N; Sawyer L; Cababa D; Hendry RM; Nara PL; Burton DR
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3809-13. PubMed ID: 8170992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibodies of HIV-1 positive subjects and experimentally immunized primates and rodents bind to sequence divergent regions of the third variable domain (V3) of gp120.
    Boudet F; Girard M; Theze J; Zouali M
    Int Immunol; 1992 Feb; 4(2):283-94. PubMed ID: 1377948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites.
    Townsley S; Li Y; Kozyrev Y; Cleveland B; Hu SL
    J Virol; 2016 Jan; 90(2):829-41. PubMed ID: 26512079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12.
    Marradi M; Di Gianvincenzo P; Enríquez-Navas PM; Martínez-Ávila OM; Chiodo F; Yuste E; Angulo J; Penadés S
    J Mol Biol; 2011 Jul; 410(5):798-810. PubMed ID: 21440555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antisera raised against the second variable region of the external envelope glycoprotein of human immunodeficiency virus type 1 cross-neutralize and show an increased neutralization index when they act together with antisera to the V3 neutralization epitope.
    Davis D; Stephens DM; Carne CA; Lachmann PJ
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2609-17. PubMed ID: 7506300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodies.
    Young KR; Teal BE; Brooks Y; Green TD; Bower JF; Ross TM
    AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1259-68. PubMed ID: 15588348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunofocusing: antigen engineering to promote the induction of HIV-neutralizing antibodies.
    Pantophlet R; Burton DR
    Trends Mol Med; 2003 Nov; 9(11):468-73. PubMed ID: 14604823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human immunodeficiency virus: novel enzyme-linked immunoassays for quantitation of envelope glycoprotein 120.
    Weiler BE; Schäcke H; Bachmann M; Brigido L; Gilbert M; Mills J; Matthes E; Forrest JM; Müller WE
    J Virol Methods; 1991 May; 32(2-3):287-301. PubMed ID: 1874921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibodies against HIV-1 from phage display libraries: mapping of an immune response and progress towards antiviral immunotherapy.
    Parren PW; Burton DR
    Chem Immunol; 1997; 65():18-56. PubMed ID: 9018871
    [No Abstract]   [Full Text] [Related]  

  • 53. Altered immunochemical reactivity of Saccharomyces cerevisiae a-cells after alpha-factor-induced morphogenesis.
    Lipke PN; Ballou CE
    J Bacteriol; 1980 Mar; 141(3):1170-7. PubMed ID: 6988408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Humoral immune response to a 200-kDa glycoprotein antigen of Saccharomyces cerevisiae is common in man.
    Sander U; Kunze I; Bröker M; Kunze G
    Immunol Lett; 1998 Apr; 61(2-3):113-7. PubMed ID: 9657263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunosorbent for the isolation of specific antibodies against mannan: localization of antigens in yeast cell walls.
    Gerber H; Horisberger M; Bauer H
    Infect Immun; 1973 Mar; 7(3):487-92. PubMed ID: 4123394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunochemical studies of the mannans of Saccharomyces cerevisiae X2180-1A-5 and Saccharomyces cerevisiae 4484-24D-1 mutant strains, with special reference to their phosphate content.
    Okubo Y; Shibata N; Matsumoto T; Suzuki M; Schuerch C; Suzuki S
    J Bacteriol; 1980 Oct; 144(1):92-6. PubMed ID: 6158512
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specificity and prevalence of natural bovine antimannan antibodies.
    Srinivasan A; Ni Y; Tizard I
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):946-52. PubMed ID: 10548591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AIDS in Africa: distinguishing fact and fiction.
    Papadopulos-Eleopulos E; Turner VF; Papadimitriou JM; Bialy H
    World J Microbiol Biotechnol; 1995 Mar; 11(2):135-43. PubMed ID: 24414488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160.
    Benjouad A; Gluckman JC; Montagnier L; Bahraoui E
    J Virol; 1993 Mar; 67(3):1693-7. PubMed ID: 7679751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120.
    Curtis BM; Scharnowske S; Watson AJ
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8356-60. PubMed ID: 1518869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.